ResearcherMayo ClinicActive in the last 2 years
Himil J Mahadevia
Matched on ORCID iD 0000-0002-2083-5510; OpenAlex author ID A5087278771. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2023: 1 paper · 2024: 2 papers · 2025: 1 paper
Papers 4
- Stereotactic body radiation therapy in oligometastatic pancreatic cancer: overall survival improvement and SMAD4 as a predictor of progression-free survival. Co-author DOI 10.21037/jgo-2025-100↗
- Identifying Actionable Alterations in KRAS Wild-Type Pancreatic Cancer. Co-author DOI 10.1007/s11523-024-01088-3↗
- An overview of up-and-coming immune checkpoint inhibitors for pancreatic cancer. Co-author DOI 10.1080/14656566.2024.2304125↗
- An Excellent Response of Microsatellite Instability-High Pancreatic Adenocarcinoma to Pembrolizumab Treatment: The Role of Circulating Tumor DNA Testing. Co-author DOI 10.7759/cureus.37239↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hani M. Babiker · 4 shared papers, 2023–2025 · strength 0.95
- Paper An overview of up-and-coming immune checkpoint inhibitors for pancreatic cancer. DOI 10.1080/14656566.2024.2304125↗
- Paper Stereotactic body radiation therapy in oligometastatic pancreatic cancer: overall survival improvement and SMAD4 as a p… DOI 10.21037/jgo-2025-100↗
- Paper Identifying Actionable Alterations in KRAS Wild-Type Pancreatic Cancer. DOI 10.1007/s11523-024-01088-3↗
- Mitesh J. Borad · 3 shared papers, 2024–2025 · strength 0.74
- Paper An overview of up-and-coming immune checkpoint inhibitors for pancreatic cancer. DOI 10.1080/14656566.2024.2304125↗
- Paper Stereotactic body radiation therapy in oligometastatic pancreatic cancer: overall survival improvement and SMAD4 as a p… DOI 10.21037/jgo-2025-100↗
- Paper Identifying Actionable Alterations in KRAS Wild-Type Pancreatic Cancer. DOI 10.1007/s11523-024-01088-3↗
- Douaa Albelal · 2 shared papers, 2024–2025 · strength 0.47
- Ahmed Elhariri · 2 shared papers, 2024–2025 · strength 0.47
- Jing Wang · 1 shared paper, 2024 · strength 0.28
- Pedro Luiz Serrano Usón · 1 shared paper, 2024 · strength 0.28
- Nguyen H. Tran · 1 shared paper, 2025 · strength 0.24
- Umair Majeed · 1 shared paper, 2025 · strength 0.24
- Michael S. Rutenberg · 1 shared paper, 2025 · strength 0.24
- Bhrugun Anisetti · 1 shared paper, 2023 · strength 0.20
- Tucker W. Coston · 1 shared paper, 2023 · strength 0.20
- Jason Scott Starr · 1 shared paper, 2023 · strength 0.20
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.